Product information
| Price | €175, €275, €395 |
|---|---|
| Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
| Short name | Podocan Antibody |
| Host | Rabbit |
| Isotype | IgG |
| Target protein | PODN |
| Recommended applications | ELISA, IHC-p |
| Reactivity | Human |
| Immunogen | Synthesized peptide derived from the C-terminal region of human Podocan. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Formulation | Liquid in PBS containing 50% glycerol; 0.5% BSA and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Product code | MB-AP14546 |
Additional information
Prev
Next
The podocan encoded by PODN is a member of the small leucine-rich repeat protein family and contains an amino terminal CX3CXCX7C cysteine-rich cluster followed by a leucine-rich repeat domain. Studies suggest that this protein could function to inhibit smooth muscle cell proliferation and migration following arterial injury.
PODN, SLRR5A, Podocan
Human: Q7Z5L7, Mouse: Q7TQ62
Human: 127435
